IP Library Patent Application 17430077
Patent Application
App. No. 17/430,077

MONONUCLEAR IRIDIUM COMPLEXES CONTAINING THREE ORTHO-METALLATED BIDENTATE LIGANDS AND OPTICAL ORIENTATING ANISTROPHY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/430,077
Abstract

The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.

Claims (48)

1 .- 18 . (canceled)

19 . A mononuclear iridium complex that exhibits oriented emission with an optical orientation anisotropy Θ≤0.24, containing three ortho-metallated bidentate ligands or three ortho-metallated bidentate sub-ligands, characterized in that the angle α(μ act ,d) between the transition dipole moment μ act and the electrical dipole moment d is ≤40°;

where the following compounds are excluded from the invention:

20 . The mononuclear iridium complex according to claim 19 , wherein the complex is a heteroleptic complex containing at least two different ligands or sub-ligands.

21 . The mononuclear iridium complex according to claim 19 , wherein the complex has two identical bidentate ligands or sub-ligands and a further bidentate ligand or sub-ligand different from the two other bidentate ligands or sub-ligands.

22 . The mononuclear iridium complex according to claim 19 , wherein the complex has exactly one optically active ligand or sub-ligand L act which is characterized in that the triplet energy is subject to the following condition: Ir(L act )<Ir(L) where L is the optically inactive ligand.

23 . The mononuclear iridium complex according to claim 22 , wherein the triplet energy of the ligand Ir(L) is at least 0.05 eV greater than that of the ligand Ir(L act ).

24 . The mononuclear iridium complex according to claim 19 , wherein the optically active ligand or sub-ligand is extended in the direction of the transition dipole moment with an aromatic or heteroaromatic ring system.

25 . The mononuclear iridium complex according to claim 19 , wherein the optical orientation anisotropy Θ is ≤0.22.

26 . The mononuclear iridium complex according to claim 19 , wherein the angle α(μ act ,d) between the transition dipole moment μ act and the electrical dipole moment d is ≤35°.

27 . The mononuclear iridium complex according to claim 19 , wherein the complex has a photoluminescence quantum efficiency of more than 0.85.

28 . The mononuclear iridium complex according to claim 19 , wherein the complex is one of the formulae (1) and (2)

where L act in formula (1) is an optically active ortho-metallated bidentate ligand and in formula (2) is an optically active ortho-metallated bidentate sub-ligand, L is different from L act and is the same or different at each instance and is ortho-metallated bidentate ligands in formula (1) and ortho-metallated bidentate sub-ligands in formula (2), and V in formula (2) is a bridging unit that joins the sub-ligands L act and L covalently to form a tripodal hexadentate ligand.

29 . The mononuclear iridium complex according to claim 28 , wherein L act and L each coordinate to the iridium via one carbon atom and one nitrogen atom or via two carbon atoms.

30 . The mononuclear iridium complex according to claim 28 , wherein L act and L each represent a structure of the formulae (L-1) or (L-2), where the two ligands or sub-ligands L may be the same or different,

where the dotted bond represents the bond of the sub-ligand in formula (2) to V and is absent for formula (1) and where the other symbols used are as follows:

CyC is the same or different at each instance and is a substituted or unsubstituted aryl or heteroaryl group which has 5 to 14 aromatic ring atoms and coordinates in each case to the metal via a carbon atom and which is bonded to CyD via a covalent bond;

CyD is the same or different at each instance and is a substituted or unsubstituted heteroaryl group which has 5 to 14 aromatic ring atoms and coordinates to the metal via a nitrogen atom or via a carbene carbon atom and which is bonded to CyC via a covalent bond;

at the same time, two or more of the optional substituents together may form a ring system.

31 . The mononuclear iridium complex according to claim 28 , wherein L act and L are each a structure of one of the formulae (L-1-1), (L-1-2), (L-2-1), (L-2-2), (L-2-3) or (L-2-4)

where “o” for compounds of the formula (2) represents the position of the bond to V, in which case the corresponding X is C, and where “o” is undefined for compounds of the formula (1), and in addition:

X is the same or different at each instance and is CR or N, with the proviso that at most two symbols X per ring are N;

R is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 1 ) 2 , OR 1 , SR 1 , CN, NO 2 , COOR 1 , C(═O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 1 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 1 ) 2 , C═O, NR 1 , O, S or CONR 1 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more nonaromatic R 1 radicals; at the same time, two R radicals together may also form a ring system;

R 1 is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 2 ) 2 , OR 2 , SR 2 , CN, NO 2 , Si(R 2 ) 3 , B(OR 2 ) 2 , C(═O)R 2 , P(═O)(R 2 ) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 2 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 2 ) 2 , C═O, NR 2 , O, S or CONR 2 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more R 2 radicals; at the same time, two or more R 1 radicals together may form a ring system;

R 2 is the same or different at each instance and is H, D, F or an aliphatic organic radical, having 1 to 20 carbon atoms, in which one or more hydrogen atoms may also be replaced by F.

32 . The mononuclear iridium complex according to claim 28 , wherein L act is a ligand or sub-ligand of the formula (L-39) that coordinates to the iridium via the two D groups and which, when the complex is one of the formula (2), is bonded to V via the dotted bond, in which case the corresponding X is C,

Wherein

X is the same or different at each instance and is CR or N, with the proviso that at most two symbols X per ring are N;

R is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 1 ) 2 , OR 1 , SR 1 , CN, NO 2 , COOR 1 , C(═O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 1 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 1 ) 2 , C═O, NR 1 , O, S or CONR 1 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more nonaromatic R 1 radicals; at the same time, two R radicals together may also form a ring system;

R 1 is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 2 ) 2 , OR 2 , SR 2 , CN, NO 2 , Si(R 2 ) 3 , B(OR 2 ) 2 , C(═O)R 2 , P(═O)(R 2 ) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 2 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 2 ) 2 , C═O, NR 2 , O, S or CONR 2 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more R 2 radicals; at the same time, two or more R 1 radicals together may form a ring system;

R 2 is the same or different at each instance and is H, D, F or an aliphatic organic radical, having 1 to 20 carbon atoms, in which one or more hydrogen atoms may also be replaced by F;

D is C or N, with the proviso that one D is C and the other D is N;

Z is CR′, CR or N, with the proviso that exactly one Z is CR′ and the other Z is CR or N;

where a maximum of one symbol X or Z per cycle is N;

R′ is a group of the following formula (14) or (15):

where the dotted bond indicates the attachment of the group;

R″ is the same or different at each instance and is H, D, F, CN, a straight-chain alkyl group having 1 to 10 carbon atoms in which one or more hydrogen atoms may also be replaced by D or F, or a branched or cyclic alkyl group having 3 to 10 carbon atoms in which one or more hydrogen atoms may also be replaced by D or F, or an alkenyl group having 2 to 10 carbon atoms in which one or more hydrogen atoms may also be replaced by D or F; at the same time, two adjacent R″ radicals or two R″ radicals on adjacent phenyl groups together may also form a ring system; or two R″ on adjacent phenyl groups together are a group selected from C(R 1 ) 2 , NR 1 , O and S, such that the two phenyl rings together with the bridging group are a carbazole, dibenzofuran or dibenzothiophene, and the further R″ are as defined above;

n is 0, 1, 2, 3, 4 or 5.

33 . The mononuclear iridium complex according to claim 28 , wherein V represents a group of the formula (16), where the dotted bonds represent the position of the attachment of the sub-ligands L act and L,

wherein

R is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 1 ) 2 , OR 1 , SR 1 , CN, NO 2 , COOR 1 , C(═O)N(R 1 ) 2 , Si(R 1 ) 3 , B(OR 1 ) 2 , C(═O)R 1 , P(═O)(R 1 ) 2 , S(═O)R 1 , S(═O) 2 R 1 , OSO 2 R 1 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 1 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 1 ) 2 , C═O, NR 1 , O, S or CONR 1 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more nonaromatic R 1 radicals; at the same time, two R radicals together may also form a ring system;

R 1 is the same or different at each instance and is H, D, F, Cl, Br, I, N(R 2 ) 2 , OR 2 , SR 2 , CN, NO 2 , Si(R 2 ) 3 , B(OR 2 ) 2 , C(═O)R 2 , P(═O)(R 2 ) 2 , S(═O)R 2 , S(═O) 2 R 2 , OSO 2 R 2 , a straight-chain alkyl group having 1 to 20 carbon atoms or an alkenyl or alkynyl group having 2 to 20 carbon atoms or a branched or cyclic alkyl group having 3 to 20 carbon atoms, where the alkyl, alkenyl or alkynyl group may in each case be substituted by one or more R 2 radicals and where one or more nonadjacent CH 2 groups may be replaced by Si(R 2 ) 2 , C═O, NR 2 , O, S or CONR 2 , or an aromatic or heteroaromatic ring system which has 5 to 40 aromatic ring atoms and may be substituted in each case by one or more R 2 radicals; at the same time, two or more R 1 radicals together may form a ring system;

R 2 is the same or different at each instance and is H, D, F or an aliphatic organic radical, having 1 to 20 carbon atoms, in which one or more hydrogen atoms may also be replaced by F;

X 1 is the same or different at each instance and is CR or N;

A is the same or different at each instance and is CR 2 —CR 2 , CR 2 —O, CR 2 —NR, C(═O)—O, C(═O)—NR or a group of the formula (17):

where the dotted bond represents the position of the bond of the bidentate sub-ligands L act and L to this structure, * represents the position of the attachment of the unit of the formula (17) to the central trivalent aryl or heteroaryl group and X 2 is the same or different at each instance and is CR or N.

34 . An electronic device comprising at least one mononuclear iridium complex according to claim 19 .

35 . Electronic device according to claim 34 , the device is an organic electroluminescent device and the mononuclear iridium complex is used as emitting compound in an emitting layer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2023
From: MERCK PATENT GMBH
To: UDC IRELAND LIMITED
Reel/Frame 064004/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2021
From: MAY, FALK; STOESSEL, PHILIPP; AUCH, ARMIN; WALTER, CHARLOTTE; PFISTER, JOCHEN; BREUNING, ESTHER
To: MERCK KGAA
Reel/Frame 057147/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2021
From: MERCK KGAA
To: MERCK PERFORMANCE MATERIALS GERMANY GMBH
Reel/Frame 057147/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2021
From: MERCK PERFORMANCE MATERIALS GERMANY GMBH
To: MERCK PATENT GMBH
Reel/Frame 057147/0546 →